Tanovea (rabacfosadine)

Tanovea® is a promising new anti-cancer drug designed to treat canine lymphoma. Most cancer treatments are initially targeted for human use and then secondarily modified for animals; however, Tanovea® was developed specifically for dogs, heralding a new ear in veterinary research and drug discovery.

Uses

Tanovea® can only be prescribed by a licensed veterinarian since the accurate diagnosis, treatment, and management of side effects are crucial for the drug’s proper use and efficacy. Tanovea® has been demonstrated to be effective against the following diseases in dogs:3

Non-Hodgkin’s lymphoma (NHL)
Canine cutaneous T-cell lymphoma
Spontaneous canine multiple myeloma
Naïve canine multicentric lymphoma
Relapsed canine B-cell lymphoma

For more information please visit: Tanovea (rabacfosadine)